Chintalapudi Kumar, MD
Pulmonary Disease · West Bloomfield, MINPI 1689838195
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,554 of the $2,545 with a category attached, or 61.0%. Edwards Lifesciences accounts for 75.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $1,960 and has fallen 88.9% since, to $217 in 2025.
Across 19 payments — averaging $133.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$2K
- AstraZeneca$121
- Abiomed$119
- Mallinckrodt Hospital Products Inc.$116
- Paratek Pharmaceuticals, Inc.$113
- Mylan Specialty L.p.$92
- plus $62 from 3 others
What the payments were for
- Travel & lodging$1,55461%
- Food & beverage$99139%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 7 | $1,924 |
| AstraZeneca | 2 | $121 |
| Abiomed | 1 | $119 |
| Mallinckrodt Hospital Products Inc. | 2 | $116 |
| Paratek Pharmaceuticals, Inc. | 1 | $113 |
| Mylan Specialty L.p. | 2 | $92 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Boehringer Ingelheim | 1 | $17 |
| GSK | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,545 in reported general payments places this provider in the 60th percentile of 463 pulmonary disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in West Bloomfield
- Meilan HanAnn Arbor$779K
- Njira LugogoAnn Arbor$741K
- Gustavo Cumbo NacheliGrand Rapids$724K
- Gary FergusonLivonia$601K
- Justin OldhamAnn Arbor$392K
- Mounir GhaliWyoming$371K
- Kevin FlahertyAnn Arbor$328K
- Podduturu ReddyPort Huron$324K
- Samuel AllenTroy$287K
- Daniel MaxwellAlpena$235K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.